Medication could boost reproductive health in women with PCOS
A study has shown that the drug semaglutide, used for weight loss, may improve reproductive health in women with polycystic ovary syndrome (PCOS). It contributed to faster improvements in ovulation and fertility results in women who lost 10% of their body weight during the clinical trial. PCOS is one of the most common hormonal disorders among women of reproductive age and is associated with irregular menstrual cycles, ovulation issues, obesity, and metabolic disorders that affect fertility. The study is still in its early stages, but the results suggest the drug’s potential to address two major problems simultaneously.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)